By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kythera (Acquired by Allergan) 

Press releases archived for reference only.
30930 Russell Ranch Road
Westlake Village  California  91362  U.S.A.
Phone: 818-587-4500 Fax: 818-587-4591


Oct. 1, 2015 -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Kythera Biopharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel prescription products for the medical aesthetics market. Allergan acquired Kythera in an all-cash transaction valued at approximately $2.1 billion.

Key Statistics

Ownership: Public

Web Site: Kythera
Symbol: KYTH

Company News
Sienna Biopharma Launches with $34 Million and a Roster Full of Former Kythera (KYTH) Execs 4/29/2016 5:53:56 AM
Allergan (AGN)'s Kythera (KYTH) to Slash 117 Jobs After Merger is Completed 10/15/2015 6:42:08 AM
Allergan (AGN) Successfully Completes Kythera (KYTH) Acquisition; Adds Game-Changing KYBELLA Treatment For Double-Chin 10/1/2015 7:45:18 AM
Allergan (AGN) And Kythera (KYTH) Announce That Pending Transaction Will Now Be For All-Cash Consideration 8/5/2015 8:15:53 AM
Allergan (AGN) And Kythera (KYTH) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Allergan's Pending Acquisition Of KYTHERA 7/28/2015 12:41:10 PM
Kythera (KYTH) Grants Stock Options Under Inducement Program 6/17/2015 7:24:04 AM
Allergan (AGN) Coughs Up $2.1 Billion for Double-Chin Drugmaker Kythera (KYTH) 6/17/2015 5:56:07 AM
Kythera (KYTH) To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/11/2015 10:33:45 AM
Kythera (KYTH) Releases First Quarter 2015 Operating Results And Progress Update 5/8/2015 7:42:25 AM
Kythera (KYTH) Grants Stock Options Under Inducement Program 5/7/2015 7:58:29 AM